Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition

Citation
Rd. Porsolt et al., Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition, ARZNEI-FOR, 50(3), 2000, pp. E232-E235
Citations number
15
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
ISSN journal
00044172 → ACNP
Volume
50
Issue
3
Year of publication
2000
Pages
E232 - E235
Database
ISI
SICI code
0004-4172(200003)50:3<E232:EOAGBE>2.0.ZU;2-N
Abstract
A standardized extract of ginkgo biloba (EGb 761) was evaluated in function al tests for monoamine oxidase (MAO) inhibition in mice: 1-dihydroxyphenyla lanine (CAS 59-92-7,1-DOPA) potentiation, tryptamine (CAS 61-54-1) potentia tion, 5-hydroxytryptophan (CAS 4350-07-6,5-HTP) potentiation and phenylethy lamine (CAS 64-04-0) potentiation. The doses investigated (25, 50 and 100 m g/kg p.o once daily for 5 days) were those known to possess antistress prop erties in other animal models. In contrast to the reference substances inve stigated (nialamide (CAS 51-12-7), clorgyline (CAS 17780-75-5) and 1-depren yl (CAS 14611-52-01), EGb 761 did not exhibit any activity indicative of MA O inhibition. It was concluded that MAO inhibition was not the mechanism pr imarily responsible for EGb 761's antistress activity.